Long COVID: century-old lessons we still have not learnt

References

1. Spinney L. Pale Rider: The Spanish Flu of 1918 and How It Changed the World. London: Vintage; 2017.
2. Rice GW. Japan and New Zealand in the 1918 Influenza Pandemic: comparative perspectives on official responses and crisis management. In: Phillips H, killingray D, eds. The Spanish Influenza Pandemic of 1918-19: New perspectives. London and New York: Routledge; 2003: 73-85.
3. Bootsma MC, Ferguson NM. The effect of public health measures on the 1918 influenza pandemic in U.S. cities. Proc Natl Acad Sci U S A 2007; 104(18): 7588-93.
4. Rice GW. Black November: “The 1918 Influenza Pandemic in New Zealand”. Revised and Enlarged Second Edition ed. Christchurch: Canterbury University Press; 2005.
5. Rice GW. Black Flu 1918: The Story of New Zealand’s Worst Public Health Disaster. Christchurch: Canterbury University Press; 2017.
6. Choutka J, Jansari V, Hornig M, Iwasaki A. Unexplained post-acute infection syndromes. Nature Medicine 2022; 28(5): 911-23.
7. Vedel Sørensen AI, Spiliopoulos L, Bager P, et al. Post-acute symptoms, new onset diagnoses and health problems 6 to 12 months after SARS-CoV-2 infection: a nationwide questionnaire study in the adult Danish population. medRxiv 2022: 2022.02.27.22271328.
8. Whitaker M, Whitaker M, Elliott J, et al. Persistent symptoms following SARS-CoV-2 infection in a random community sample of 508,707 people. medRxiv 2021.
9. Ayoubkhani D, Khunti K, Nafilyan V, et al. Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study. BMJ 2021; 372: n693.
10. Ehwerhemuepha L, Carlson K, Moog R, et al. Cerner real-world data (CRWD) – A de-identified multicenter electronic health records database. Data in Brief 2022; 42: 108120.
11. Bull-Otterson L, Baca S, Saydah S, et al. Post–COVID Conditions Among Adult COVID-19 Survivors Aged 18–64 and ≥65 Years — United States, March 2020–November 2021. MMWR Morbidity and Mortality Weekly Report 2022; 71(21): 713-7.
12. Potter JD. Long COVID: a crucial reason for vax, mask, and distance. Public Health Expert. https://blogs.otago.ac.nz/pubhealthexpert/long-covid-a-crucial-reason-for-vax-mask-and-distance/#more-19237: University of Otago; 2022.
13. Wong-Chew RM, Rodriguez Cabrera EX, Rodriguez Valdez CA, et al. Symptom cluster analysis of long COVID-19 in patients discharged from the Temporary COVID-19 Hospital in Mexico City. Ther Adv Infect Dis 2022; 9: 20499361211069264.
14. Wulf Hanson S, Abbafati C, Aerts JG, et al. A global systematic analysis of the occurrence, severity, and recovery pattern of long COVID in 2020 and 2021. medRxiv 2022: 2022.05.26.22275532.
15. Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV. A clinical case definition of post-COVID-19 condition by a Delphi consensus. The Lancet Infectious Diseases 2022; 22(4): e102-7.
16. World Health Organization. A clinical case definition of post COVID-19 condition by a Delphi consensus. https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1: WHO, 2021.
17. Salomon JA, Haagsma JA, Davis A, et al. Disability weights for the Global Burden of Disease 2013 study. Lancet Glob Health 2015; 3(11): e712-23.
18. FAIR Health. A Detailed Study of Patients with Long-Haul COVID: An Analysis of Private Healthcare Claims. https://bit.ly/3v8RSQv: FAIR Health, Inc., 2021.
19. Doykov I, Hallqvist J, Gilmour KC, Grandjean L, Mills K, Heywood WE. ‘The long tail of Covid-19’ – The detection of a prolonged inflammatory response after a SARS-CoV-2 infection in asymptomatic and mildly affected patients. F1000Res 2020; 9: 1349.
20. Cirulli ET, Schiabor Barrett KM, Riffle S, et al. Long-term COVID-19 symptoms in a large unselected population. medRxiv 2020: 2020.10.07.20208702.
21. Helms J, Kremer S, Merdji H, et al. Neurologic Features in Severe SARS-CoV-2 Infection. N Engl J Med 2020; 382(23): 2268-70.
22. Gupta A, Madhavan MV, Sehgal K, et al. Extrapulmonary manifestations of COVID-19. Nat Med 2020; 26(7): 1017-32.
23. Xie Y, Xu E, Bowe B, Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat Med 2022; 28(3): 583-90.
24. Long B, Brady WJ, Koyfman A, Gottlieb M. Cardiovascular complications in COVID-19. Am J Emerg Med 2020; 38(7): 1504-7.
25. Kommoss FKF, Schwab C, Tavernar L, et al. The Pathology of Severe COVID-19-Related Lung Damage. Dtsch Arztebl Int 2020; 117(29-30): 500-6.
26. Douaud G, Lee S, Alfaro-Almagro F, et al. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature 2022; 604(7907): 697-707.
27. Bowe B, Xie Y, Xu E, Al-Aly Z. Kidney Outcomes in Long COVID. J Am Soc Nephrol 2021; 32(11): 2851-62.
28. Hultstrom M, Lipcsey M, Wallin E, Larsson IM, Larsson A, Frithiof R. Severe acute kidney injury associated with progression of chronic kidney disease after critical COVID-19. Crit Care 2021; 25(1): 37.
29. Sathish T, Kapoor N, Cao Y, Tapp RJ, Zimmet P. Proportion of newly diagnosed diabetes in COVID-19 patients: A systematic review and meta-analysis. Diabetes Obes Metab 2021; 23(3): 870-4.
30. Kresch E, Achua J, Saltzman R, et al. COVID-19 Endothelial Dysfunction Can Cause Erectile Dysfunction: Histopathological, Immunohistochemical, and Ultrastructural Study of the Human Penis. World J Mens Health 2021; 39(3): 466-9.
31. Al-Aly Z, Bowe B, Xie Y. Outcomes of SARS-CoV-2 Reinfection. Research Square Preprint 2022.
32. UK Health Security Agency. The effectiveness of vaccination against long COVID: A rapid evidence briefing. https://ukhsa.koha-ptfs.co.uk/cgi-bin/koha/opac-retrieve-file.pl?id=fe4f10cd3cd509fe045ad4f72ae0dfff: UK Health Security Agency, 2022.
33. Ayoubkhani D, Bosworth ML, King S, et al. Risk of Long Covid in people infected with SARS-CoV-2 after two doses of a COVID-19 vaccine: community-based, matched cohort study. medRxiv 2022: 2022.02.23.22271388.
34. Office for National Statistics. Self-reported long COVID after infection with the Omicron variant in the UK: 6 May 2022. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/selfreportedlongcovidafterinfectionwiththeomicronvariant/6may2022/pdf: Office for National Statistics, 2022.
35. Morioka S, Tsuzuki S, Suzuki M, et al. Post COVID-19 condition of the Omicron variant of SARS-CoV-2. medRxiv 2022: 2022.05.12.22274990.
36. Lewnard JA, Hong VX, Patel MM, Kahn R, Lipsitch M, Tartof SY. Clinical outcomes associated with SARS-CoV-2 Omicron (B.1.1.529) variant and BA.1/BA.1.1 or BA.2 subvariant infection in southern California. Nat Med 2022.
37. Ayoubkhani D, Bermingham C, Pouwels KB, et al. Trajectory of long covid symptoms after covid-19 vaccination: community based cohort study. BMJ 2022; 377: e069676.
38. Ali ST, Kang AK, Patel TR, et al. Evolution of neurologic symptoms in non-hospitalized COVID-19 “long haulers”. Ann Clin Transl Neurol 2022; n/a(n/a).
39. Tognotti E. Lessons from the history of quarantine, from plague to influenza A. Emerg Infect Dis 2013; 19(2): 254-9.
40. Tognotti E. Scientific triumphalism and learning from facts: bacteriology and the “Spanish flu” challenge of 1918. Soc Hist Med 2003; 16(1): 97-110.